Showing results (71-80 of 149) with videos related to
Sort By:
Pageof 15
Neurobiology of Aging|January 1, 1988
Cognitive and brain imaging measures of Alzheimer's diseaseN R CutlerJournal of Clinical Psychopharmacology|December 1, 1996
Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging studyJ J Sramek, A Fresquet, G Marion-Landais, et al.Clinical Pharmacology and Therapeutics|July 1, 1995
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamicsN R Cutler, R D Seifert, M M Schleman, et al.The Mount Sinai Journal of Medicine, New York|October 1, 1996
Ethnicity and antidepressant responseJ J Sramek, E H PiJournal of Clinical Pharmacology|January 5, 2002
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adultsD E Salazar, E J Frackiewicz, R Dockens, et al.Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.Journal of Clinical Psychopharmacology|October 1, 1982
State-related cyclical dyskinesias in manic-depressive illnessN R Cutler, R M PostThe Psychiatric Clinics of North America|December 1, 1984
Implications of dosing tricyclic antidepressants and benzodiazepines in geriatricsN R Cutler, P K NarangDrug Intelligence & Clinical Pharmacy|March 1, 1981
Psychotic exacerbation with haloperidolF L Tornatore, D Lee, J J SramekPageof 15